Nkx2–5 is dysregulated in acute lymphoblastic leukemia (ALL), hepatocellular carcinoma (HCC), and T cell neoplasias, methylated in prostate adenocarcinoma, hyper-methylated in salivary gland adenoid cystic carcinoma [168]. The gene discussed is NKX2-5; the disease is prostate adenocarcinoma.